Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

New Technology

Set Alert for New Technology

Abbott Receives Emergency Use Authorization For COVID-19 Test

Abbott has become the next major diagnostics company to receive an Emergency Use Authorization from the US FDA for a COVID-19 test.

Coronavirus COVID-19 Infectious Diseases In Vitro Diagnostics

Latest From Innovation

ACC 2020: SPYRAL HTN-OFF MED Results Support Medtronic’s Renal Denervation System

Three-month results of the SPYRAL HTN-OFF MED pivotal trial show renal denervation with Medtronic’s Symplicity Spyral system significantly reduced blood pressure in hypertensive patients not taking anti-hypertensive medications.

Clinical Trials Innovation

COVID-19 Raises Demand For Butterfly's Single-Probe Ultrasound System

Butterfly Network is disseminating the lessons from China and Italy about the poential value of lung ultrasound in the management of COVID-19 patients with respiratory disease.

Coronavirus COVID-19 Clinical Trials

Start-Up Spotlight: Iraq War Veteran Deploys ‘Bone Paint’ To Combat Traumatic Injuries

Theradaptive's “paint-like” regenerative therapeutic can be applied to any device to promote bone regrowth or regenerate tissue.

Commercial Innovation

QUOTED. 24 March 2020. Joseph Brennan.

US telehealth companies are seeing skyrocketing demand for devices and services. See what Joseph Brennan, a telehealth expert at Moonshot Health Consulting, said about it here.

Quoted Infectious Diseases

Telehealth Sees Skyrocketing Demand Amid Regulatory Expansion, Hopes To Last Beyond COVID-19 Crisis

US telehealth companies are seeing skyrocketing demand for devices and services, which offers opportunities and challenges during this COVID-19 crisis.

Infectious Diseases Coronavirus COVID-19

FDA Says AI Regulations May Require More Congressional Authorities

The top official on artificial intelligence products at the US FDA says that while the agency has some authorities to implement regulatory oversight, it may need additional powers from Congress considering the direction the FDA may possibly take in regulating AI and machine learning products.

Artificial Intelligence FDA

UK Court Blocks Edwards’ TAVR Device For Patent Infringement

Edwards’ Pascal transcatheter valve repair devices has been blocked from most use after being found to infringe on Abbott’s patents by a British court.

United Kingdom Commercial

Device Week, 18 March 2020 – Canceled Surgeries, New Medtech Alliances

In this episode of our weekly podcast, Medtech Insight managing editor Marion Webb talks with deputy editor Reed Miller about her story on US hospitals canceling elective surgeries to preserve critical resources in response to COVID-19, and hospitals joining forces with medtechs to find rapid technological solutions to keep patients and caregivers healthy.

Device Week Coronavirus COVID-19

QUOTED. 18 March 2020. Julian Goldman.

US health systems are canceling elective surgeries in response to COVID-19 to preserve critical resources. See what Julian Goldman, anesthesiologist and director of the Medical Device Interoperability and Cybersecurity program at Massachusetts General Hospital, had to say about the potential ramifications.

Quoted Innovation
See All
UsernamePublicRestriction

Register